A 3-day hospital stay after pancreas tail surgery
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial tests whether it's safe and practical to send patients home just 3 days after a minimally invasive distal pancreatectomy (removing the tail of the pancreas). It's for people who have good support at home and live close to the hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and having a minimally invasive (laparoscopic or robotic) distal pancreatectomy.
- You need to live within about 30 minutes' drive or 50 km from the hospital (or have a temporary place nearby).
- You must have someone at home to help you around the clock for at least the first 7 days after surgery.
- You cannot be taking strong painkillers (opioids) regularly before surgery.
- You must not need extensive surgery (removing more than one organ) or have serious health problems that need hospital stay longer than 3 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares standard laparoscopic surgery to surgery using a green dye that helps the surgeon see the pancreas more clearly. It may help patients needing removal of tumors in the body or tail of the pancreas.
This study compares two surgeries for pancreatic cancer: laparoscopic (keyhole) pancreaticoduodenectomy and open pancreaticoduodenectomy. It aims to see which approach leads to fewer complications during recovery.
This trial compares two standard approaches after surgery to remove the tail of the pancreas: placing a temporary drain or not placing one. The goal is to see which method leads to better recovery and fewer complications.
This study tests a 4-week intensive rehabilitation program for people who develop serious complications after surgery to remove part or all of the pancreas. The program combines exercise and nutrition to help you recover better at home after leaving the hospital.
This trial compares two surgical strategies to help prevent return of cancer after surgery for pancreatic body and tail ductal adenocarcinoma. You may be eligible if your cancer looks removable before surgery and your overall health and lab tests are within allowed ranges.
This trial tests a program to help patients recover faster after minimally invasive pancreatic surgery. It aims to improve outcomes by following a set of care steps before, during, and after surgery.
Hear when a new Pancreatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.